These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19854409)

  • 1. The "off-label" role of recombinant factor VIIa in surgery: is the problem deficient evidence or defective concept?
    Al-Ruzzeh S; Navia JL
    J Am Coll Surg; 2009 Nov; 209(5):659-67. PubMed ID: 19854409
    [No Abstract]   [Full Text] [Related]  

  • 2. Caution with the published database reviews analyzing the off-label use of recombinant activated factor VII (rFVIIa) in cardiac surgery.
    Al-Ruzzeh S; Navia JL
    Transfus Apher Sci; 2010 Oct; 43(2):245-6. PubMed ID: 20675193
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
    Yilmaz BT; Alioglu B; Ozyurek E; Akay HT; Mercan S; Ozbek N
    Pediatr Cardiol; 2005; 26(6):843-5. PubMed ID: 15690232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII: current perspectives and Epworth experience.
    Labattaglia MP; Ihle B
    Heart Lung Circ; 2007; 16 Suppl 3():S96-101. PubMed ID: 17627885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns.
    Bianchi A; Jackson D; Maitz P; Thanakrishnan G
    Thromb Haemost; 2004 Jan; 91(1):203-4. PubMed ID: 14691589
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of surgical procedures in children with severe FV deficiency: experience of 13 surgeries.
    Mathias M; Tunstall O; Khair K; Liesner R
    Haemophilia; 2013 Mar; 19(2):256-8. PubMed ID: 23173600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant factor VIIa in the perioperative period.
    Levi M
    Hamostaseologie; 2009 Jan; 29(1):68-70. PubMed ID: 19151850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of intractable hemorrhage with recombinant factor VIIa during cranial vault reconstruction in an infant.
    Stricker PA; Petersen C; Fiadjoe JE; McCloskey JJ
    Paediatr Anaesth; 2009 Aug; 19(8):806-7. PubMed ID: 19624375
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
    Silver DA; D'Ambra MN
    Crit Care Med; 2007 Jul; 35(7):1782-3. PubMed ID: 17581365
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple doses of recombinant factor VIIa in orthotopic liver transplantation: a case report.
    Nonthasoot B; Nivatvongs S
    Transplant Proc; 2003 Feb; 35(1):427-8. PubMed ID: 12591472
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients.
    Lee AI; Campigotto F; Rawn JD; Neuberg D; Kaufman RM; Berliner N
    Br J Haematol; 2012 May; 157(3):397-400. PubMed ID: 22224596
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the off-label use of recombinant activated factor VII in a developing country tertiary care center.
    El Accaoui R; Isma'eel H; Khalil PB; Taher A
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):647-50. PubMed ID: 17102651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eComment. Recombinant activated factor VII in pediatric cardiac surgery: possibilities and limitations.
    Bockeria LA; Kupryashov AA; Samsonova NN
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):694-5. PubMed ID: 22991396
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
    Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
    Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of activated recombinant factor VII in cardiac surgical patients.
    Hardy JF; Bélisle S; Van der Linden P
    Curr Opin Anaesthesiol; 2009 Feb; 22(1):95-9. PubMed ID: 19295298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence and desperation in off-label prescribing: recombinant factor VIIa.
    Lipworth W; Kerridge I; Little M; Day R
    BMJ; 2012 Jan; 344():d7926. PubMed ID: 22250217
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant factor VIIa and the surgical patient.
    Scarpelini S; Rizoli S
    Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traumatic haemorrhage: a role for recombinant factor VIIa?
    Spivey MH; Duffy MR
    Anaesthesia; 2009 Oct; 64(10):1141-2. PubMed ID: 19735409
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant factor VIIa in massive obstetric haemorrhage.
    Bhuskute N; Kritzinger S; Dakin M
    Eur J Anaesthesiol; 2008 Mar; 25(3):250-1. PubMed ID: 18226279
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemostatic management in high-risk cardiac surgery: a role of recombinant factor VIIa (NovoSeven RT).
    Petricevic M; Biocina B; Konosic S; Burcar I
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):606-7. PubMed ID: 22504897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.